BRPI0915291A2 - point of care test for detection of dengue virus exposure or immunity - Google Patents

point of care test for detection of dengue virus exposure or immunity

Info

Publication number
BRPI0915291A2
BRPI0915291A2 BRPI0915291A BRPI0915291A BRPI0915291A2 BR PI0915291 A2 BRPI0915291 A2 BR PI0915291A2 BR PI0915291 A BRPI0915291 A BR PI0915291A BR PI0915291 A BRPI0915291 A BR PI0915291A BR PI0915291 A2 BRPI0915291 A2 BR PI0915291A2
Authority
BR
Brazil
Prior art keywords
immunity
detection
point
dengue virus
care test
Prior art date
Application number
BRPI0915291A
Other languages
Portuguese (pt)
Inventor
Kumar Sil Bijon
yun ying Tan
Original Assignee
Mp Biomedicals Asia Pacific Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mp Biomedicals Asia Pacific Pte Ltd filed Critical Mp Biomedicals Asia Pacific Pte Ltd
Publication of BRPI0915291A2 publication Critical patent/BRPI0915291A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0915291A 2008-05-15 2009-04-15 point of care test for detection of dengue virus exposure or immunity BRPI0915291A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG200803904-2A SG157244A1 (en) 2008-05-15 2008-05-15 Point of care test for the detection of exposure or immunity to dengue virus
PCT/SG2009/000138 WO2009139725A1 (en) 2008-05-15 2009-04-15 Point of care test for the detection of exposure or immunity to dengue virus

Publications (1)

Publication Number Publication Date
BRPI0915291A2 true BRPI0915291A2 (en) 2016-02-16

Family

ID=41318932

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915291A BRPI0915291A2 (en) 2008-05-15 2009-04-15 point of care test for detection of dengue virus exposure or immunity

Country Status (7)

Country Link
BR (1) BRPI0915291A2 (en)
CO (1) CO6311040A2 (en)
CR (1) CR11836A (en)
EC (1) ECSP10010680A (en)
MX (1) MX2010012363A (en)
SG (1) SG157244A1 (en)
WO (1) WO2009139725A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG165194A1 (en) * 2009-03-20 2010-10-28 Mp Biomedicals Asia Pacific Pte Ltd Point of care test for the detection of exposure to hev immunoglobulin a (iga)
CN102393454A (en) * 2011-08-24 2012-03-28 中国检验检疫科学研究院 Colloidal gold test strip for detecting dengue virus antibody and preparation method and application thereof
CA3177574A1 (en) 2013-03-15 2014-09-25 Takeda Vaccines, Inc. Compositions and methods for dengue virus chimeric constructs in vaccines
SG10201404571PA (en) * 2014-08-01 2016-03-30 Mp Biomedicals Asia Pacific Pte Ltd Method and kit for detecting a dengue virus infection
US20220226401A1 (en) 2018-09-05 2022-07-21 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
EP4138913A1 (en) * 2020-04-24 2023-03-01 Massachusetts Institute of Technology Rapid, point of care detection of neutralizing antibodies against a virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03148066A (en) * 1989-11-06 1991-06-24 Nippon Zeon Co Ltd Membrane for diagnosing virus infectious disease and diagnostic method
EP1005363B1 (en) * 1997-07-31 2006-03-29 Hawaii Biotech, Inc. Recombinant dimeric envelope vaccine against flaviviral infection
FR2767324B1 (en) * 1997-08-14 2001-04-06 Pasteur Institut USE OF RECOMBINANT ENVELOPE PROTEINS FOR THE DIAGNOSIS OF DENGUE VIRUS
WO2005014627A1 (en) * 2003-08-07 2005-02-17 International Centre For Genetic Engineering And Biotechnology Recombinant dengue multi epitope proteins as diagnostic intermediates
SG137711A1 (en) * 2006-05-11 2007-12-28 Nat Environment Agency Antigen capture anti-dengue iga elisa (aca-elisa) for the detection of a flavivirus specific antibody

Also Published As

Publication number Publication date
MX2010012363A (en) 2011-04-11
SG157244A1 (en) 2009-12-29
WO2009139725A1 (en) 2009-11-19
CR11836A (en) 2011-06-07
ECSP10010680A (en) 2011-04-29
CO6311040A2 (en) 2011-08-22

Similar Documents

Publication Publication Date Title
BRPI0915291A2 (en) point of care test for detection of dengue virus exposure or immunity
BRPI0811232A2 (en) RESPIRATORY COMPONENT MEASURING SYSTEM.
BRPI1012990A2 (en) "analyte monitoring device and methods of use"
BRPI0920583A2 (en) aine topical compositions having sensitive component
BRPI0907272A2 (en) "Evaluation method and device for the assessment of perfusion vessels"
BRPI0918502A2 (en) substituted aminoindans and analogs thereof, and their pharmaceutical use
BRPI0922689A2 (en) neurotensin conjugates or neurotensin analogs and uses thereof
BR112012008729A2 (en) '' Health care monitoring system and method for monitoring the use of a set of health care practices ''
DE602007010480D1 (en) BLOOD SENSOR AND THESE INCLUDING BLOOD TESTING INSTRUMENT
BRPI0922691A2 (en) leptin conjugates and leptin analogs and uses thereof
BRPI0918868A2 (en) nmda receptor modulators and uses thereof
BRPI0905942A2 (en) "sample capture device"
BRPI0920927A2 (en) azaquinolinone derivatives and uses thereof
BR112012011646A2 (en) physical fitness testing system and computer program product
BRPI0923169A2 (en) "pressure sensitive paste composition and medical device"
BR112012003842A2 (en) pharmaceutical composition, method of formulation and use thereof
BRPI0814355A2 (en) IMMUNOGLOBULIN CLIVING FRAGMENTS AS DISEASE INDICATORS AND COMPOSITIONS FOR THE DETECTION AND CONNECTION OF THE SAME
BRPI0814849A2 (en) COMPACT WASH GUT SYSTEM
BRPI0917661A2 (en) product containing macitentan, pharmaceutical composition containing it and use of macitentan
BRPI0921026A2 (en) assessment of an individual's circulatory system
BRPI0813926A2 (en) USE OF A SUBSTANCE, COMPOSITION AND METHODS FOR ASSESSING ACTIVE PRINCIPLES INHIBITING TRAINING OF AGES AND COSMETIC CARE.
DE102009036844B8 (en) Exposure determining device and program product
BRPI0910161A2 (en) "method of sterilization of an object, and sterilization apparatus"
BRPI0918386A2 (en) methods of patient evaluation for stress urinary incontinence, patient assessment system for stress urinary incontinence and device for assessment of patient for stress urinary incontinence
BRPI0921230A2 (en) neuropeptide-2 (y-2r) receptor agonists and uses thereof.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired